GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » EBITDA Margin %

Beijing Health Guard Biotechnology (BJSE:833575) EBITDA Margin % : -509,753.85% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beijing Health Guard Biotechnology's EBITDA for the three months ended in Mar. 2025 was ¥-66.27 Mil. Beijing Health Guard Biotechnology's Revenue for the three months ended in Mar. 2025 was ¥0.01 Mil. Therefore, Beijing Health Guard Biotechnology's EBITDA margin for the quarter that ended in Mar. 2025 was -509,753.85%.


Beijing Health Guard Biotechnology EBITDA Margin % Historical Data

The historical data trend for Beijing Health Guard Biotechnology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology EBITDA Margin % Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -168,984.88 -134,070.18 -14,631.51 -15,908.60 -36,887.36

Beijing Health Guard Biotechnology Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59,823.24 -42,124.24 -35,694.69 -29,508.58 -509,753.85

Competitive Comparison of Beijing Health Guard Biotechnology's EBITDA Margin %

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Health Guard Biotechnology's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's EBITDA Margin % falls into.


;
;

Beijing Health Guard Biotechnology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beijing Health Guard Biotechnology's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-326.822/0.886
=-36,887.36 %

Beijing Health Guard Biotechnology's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-66.268/0.013
=-509,753.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology  (BJSE:833575) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Beijing Health Guard Biotechnology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology Headlines

No Headlines